152 related articles for article (PubMed ID: 29278579)
21. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
[TBL] [Abstract][Full Text] [Related]
22. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.
Briganti A; Larcher A; Abdollah F; Capitanio U; Gallina A; Suardi N; Bianchi M; Sun M; Freschi M; Salonia A; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2012 Mar; 61(3):480-7. PubMed ID: 22078338
[TBL] [Abstract][Full Text] [Related]
23. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
Eden CG; Arora A; Rouse P
BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
[TBL] [Abstract][Full Text] [Related]
24. Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates.
Nagaya N; Chua KJ; Sterling J; Horie S; Kim IY
Prostate Int; 2023 Jun; 11(2):107-112. PubMed ID: 37409090
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of Magnetometer-Guided Sentinel Lymphadenectomy after Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Prostate Cancer: The SentiMag Pro II Study.
Winter A; Engels S; Goos P; Süykers MC; Gudenkauf S; Henke RP; Wawroschek F
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877623
[TBL] [Abstract][Full Text] [Related]
26. Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer.
Kjölhede H; Bratt O; Gudjonsson S; Sundqvist P; Liedberg F
Scand J Urol; 2015 Apr; 49(2):97-102. PubMed ID: 25331366
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.
Pouw JJ; Grootendorst MR; Bezooijen R; Klazen CA; De Bruin WI; Klaase JM; Hall-Craggs MA; Douek M; Ten Haken B
Br J Radiol; 2015; 88(1056):20150634. PubMed ID: 26492466
[TBL] [Abstract][Full Text] [Related]
28. A Specific Mapping Study Using Fluorescence Sentinel Lymph Node Detection in Patients with Intermediate- and High-risk Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection.
Nguyen DP; Huber PM; Metzger TA; Genitsch V; Schudel HH; Thalmann GN
Eur Urol; 2016 Nov; 70(5):734-737. PubMed ID: 26856960
[TBL] [Abstract][Full Text] [Related]
29. Detection rate and operating time required for gamma probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging.
Warncke SH; Mattei A; Fuechsel FG; Z'Brun S; Krause T; Studer UE
Eur Urol; 2007 Jul; 52(1):126-32. PubMed ID: 17258385
[TBL] [Abstract][Full Text] [Related]
30. Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
von Deimling M; Furrer M; Mertens LS; Mari A; van Ginkel N; Bacchiani M; Maas M; Pichler R; Li R; Moschini M; Bianchi A; Vetterlein MW; Lonati C; Crocetto F; Taylor J; Tully KH; Afferi L; Soria F; Del Giudice F; Longoni M; Laukhtina E; Antonelli A; Rink M; Fisch M; Lotan Y; Spiess PE; Black PC; Kiss B; Pradere B; Shariat SF;
BJU Int; 2024 Mar; 133(3):341-350. PubMed ID: 37904652
[TBL] [Abstract][Full Text] [Related]
31. [Application of sentinel lymph node tracer techniques in prostate caner].
Wang C; Zhang S; Yang L
Zhonghua Nan Ke Xue; 2016 Sep; 22(9):850-855. PubMed ID: 29071886
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
[TBL] [Abstract][Full Text] [Related]
33. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
34. Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy.
Abdi H; Pourmalek F; Gleave ME; So AI; Black PC
World J Urol; 2016 Jan; 34(1):41-8. PubMed ID: 26621208
[TBL] [Abstract][Full Text] [Related]
35. A systematic review and meta-analysis of comparative studies on the efficacy of extended pelvic lymph node dissection in patients with clinically localized prostatic carcinoma.
Gao L; Yang L; Lv X; Bu S; Wan F; Qian S; Wei Q; Han P; Fan T
J Cancer Res Clin Oncol; 2014 Feb; 140(2):243-56. PubMed ID: 24369378
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
[TBL] [Abstract][Full Text] [Related]
37. Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland.
Fumadó L; Abascal JM; Mestre-Fusco A; Vidal-Sicart S; Aguilar G; Juanpere N; Cecchini L
Front Med (Lausanne); 2022; 9():931867. PubMed ID: 36117970
[TBL] [Abstract][Full Text] [Related]
38. A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis.
Ding G; Tang G; Wang T; Zou Q; Cui Y; Wu J
Int J Surg; 2024 Mar; 110(3):1735-1743. PubMed ID: 38052016
[TBL] [Abstract][Full Text] [Related]
39. A new bimodal approach for sentinel lymph node imaging in prostate cancer using a magnetic and fluorescent hybrid tracer.
Michalik B; Engels S; Otterbach MC; Frerichs J; Suhrhoff PE; van Oosterom MN; Maurer MH; Wawroschek F; Winter A
Eur J Nucl Med Mol Imaging; 2023 Nov; ():. PubMed ID: 37999812
[TBL] [Abstract][Full Text] [Related]
40. Indication to pelvic lymph nodes dissection for prostate cancer: the role of multiparametric magnetic resonance imaging when the risk of lymph nodes invasion according to Briganti updated nomogram is <5.
Porpiglia F; Manfredi M; Mele F; Bertolo R; Bollito E; Gned D; De Pascale A; Russo F; Passera R; Fiori C; De Luca S
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):85-91. PubMed ID: 29472629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
